Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

Background. We conducted this study to assess the effect of disease-modifying therapies (DMTs) on coronavirus disease (COVID-19) susceptibility and severity in people with multiple sclerosis (MS). Methods. Available studies from PubMed, Scopus, EMBASE, Web of Science, and gray literature, including...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Multiple sclerosis international Ročník 2022; s. 1 - 13
Hlavní autori:	Barzegar, Mahdi, Houshi, Shakiba, Sadeghi, Erfan, Hashemi, Mozhgan Sadat, Pishgahi, Ghasem, Bagherieh, Sara, Afshari-Safavi, Alireza, Mirmosayyeb, Omid, Shaygannejad, Vahid, Zabeti, Aram
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Egypt Hindawi 21.09.2022 John Wiley & Sons, Inc
Predmet:	Analysis Biological response modifiers Cohort analysis Coronaviruses COVID-19 Development and progression Disease susceptibility Disease transmission Health aspects Hospitalization Immunotherapy Infections Interferon Medical research Medicine, Experimental Meta-analysis Monoclonal antibodies Mortality Multiple sclerosis Pandemics Pharmacovigilance Population Review Severe acute respiratory syndrome coronavirus 2 Software Systematic review Iran United States > US Europe Spain
ISSN:	2090-2654, 2090-2662
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!